Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Lahontan Drills 10.7m Grading 1.81 g/t Au and 64.8 g/t Ag, Completes Santa Fe Mine Stockpile Drill Program
-
FutureFeed and CyberIllumination Achieve FedRAMP High Authorized (Class D) Status, the Federal Government's Highest Cloud Security Bar
-
Influential Canadian Leaders Unite in Support of Quality Early Childhood Education
-
Bond Fluidaire and West Michigan Rubber Change Name to Exotic Automation
-
Filigran Adds Attack Chaining to OpenAEV for Autonomous Penetration Testing and Red Teaming
-
Beyond Scalp: New study Suggests Role for Elissara® in Hair Growth
-
Apollo Silver Announces Chief Financial Officer Transition
-
Parabilis Medicines to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
-
Tagup Names Major General David W. Maxwell to Defense Advisory Board
-
YCharts Makes Inc. 5000 List 10th Consecutive Year
-
Adicet Bio Announces Completion of Last Patient Visit for Planned Analysis of prula-cel (formerly ADI-001) Study in Patients with Systemic Lupus Erythematosus With or Without Lupus Nephritis and Provi
-
Freestyle Celebrates 45 Years of the Original Surf Watch With the Since '81 Shark Classic Anniversary Collection
-
Craig Fernsler on How a 1031 Exchange Actually Works
-
Xentria Advances XTMAB-16 Clinical Development in Pulmonary Sarcoidosis Following FDA Feedback
-
Harrow to Participate in Three Investor Conferences in September
-
Classico Blends Two Sunday Traditions in One Jar with New Sunday Football Sauce
-
VedaBio Selects UCP Merchant Medicine to Position Its Target Amplification-Free CRISPR Molecular Diagnostics for Urgent Care
-
AstraZeneca completes global license agreement for oral EGFR inhibitor ZEGFROVY® (sunvozertinib) for lung cancer
-
SupplyCaddy Secures Additional Growth Capital from CEAS Investments
-
Introducing anywear, an On-Demand Messaging Platform That Brings Professional Styling to Everyone
-
When Music Becomes an Act of Freedom: Shuja Rabbani Challenges the Silence
-
Fingerprint Surpasses $50M ARR and Scales the Next Generation of AI-Driven Fraud Defense
-
Texas State Florists' Association Welcomes 2026-2027 Board of Directors
-
Enanta Pharmaceuticals to Participate in September Investor Conferences
-
AEye’s Apollo™ Lidar Selected by Lunar Outpost for Pegasus Lunar Terrain Vehicle, Opening a New Market Category in Space Mobility
-
Medable and ICON Exceed Patient eConsent Adoption Goals for Women’s Health Study on Menopause
-
GinaTheFashionista Announces Flat Fee Personal Styling Services for Women Across the Greater Philadelphia Area
-
Little Caesars Strengthens Military Footprint with New Navy Base Locations Across the U.S.
-
United Therapeutics Corporation Announces Participation at Upcoming Investor Conferences
-
Auddia Announces Influence Healthcare’s First Specialty Hospital LOI, Marking a Major Milestone in the Company’s Healthcare Expansion
-
Rockwell Automation to Present at Morgan Stanley 14th Annual Laguna Conference
-
CoreSite Announces Access to Oracle Cloud San Jose Region Through OCI FastConnect
-
Great Hill Partners Announces Strategic Investment in Aurenity
-
908 Devices to Present at the 32nd Annual Gabelli Aerospace & Defense Symposium
-
Otis CEO to Speak at Morgan Stanley Conference
-
Bunge Announces the Sale of its Two Sugarcane Mills in Brazil
-
Iron Mountain to Present at Upcoming Financial Conferences
-
Solen Software Group Launches AI Innovation Center in São Carlos, SP, Brazil
-
Antrique Joins the MIT Industrial Liaison Program and Startup Exchange (ILP & STEX) to Expand its Global Innovation Network
-
Innovative Beverage Concepts Marks 30 Years of Premium Beverage Innovation Serving the Global Foodservice Industry
-
Polestar Sets the Date for Reporting the Second Quarter Select and Half-Year 2026 Results
-
RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring’s Rebyota® and Clenpiq®
-
Cielo Announces Appointment of Chief Financial Officer
-
BlossomHill Therapeutics to Present Updated Data from Ongoing Phase 1/2 SOLARA Trial of its Macrocyclic OMNI-EGFR™ Inhibitor, BH-30643, in EGFR-mutant NSCLC at the 2026 World Conference on Lung Canc
-
NOVONIX Selected for South Korea-U.S. Infrastructure Initiative
-
CW Petroleum Corp (OTCQB: CWPE) Reports Financial Results for the Six Months Ended June 30, 2026
-
Processa Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Award-Winning BrewDog Unleashes Liquid Visions, a Bold New Craft Beer Series Built to Light Up Retail Shelves
-
Satellos to Participate in Upcoming Investor Conferences
-
Beam Therapeutics Appoints Eric Foster as Chief Commercial Officer
